The present meta-analysis was intentionally restricted to European Caucasian populations to minimize population stratification and genetic heterogeneity, which could otherwise confound the association between CYP3A4 polymorphisms and prostate cancer risk. Here, CYP3A4 is linked to prostate carcinoma.